Clinical Research
Copyright ©The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 7, 2005; 11(29): 4552-4559
Published online Aug 7, 2005. doi: 10.3748/wjg.v11.i29.4552
Clinical analysis of surgical treatment of portal hypertension
Xin-Bao Xu, Jing-Xiu Cai, Xi-Sheng Leng, Jia-Hong Dong, Ji-Ye Zhu, Zhen-Ping He, Fu-Shun Wang, Ji-Run Peng, Ben-Li Han, Ru-Yu Du
Xin-Bao Xu, Xi-Sheng Leng, Ji-Ye Zhu, Fu-Shun Wang, Ji-Run Peng, Ru-Yu Du, Department of Hepatobiliary Surgery, People’s Hospital, Peking University, Beijing 100044, China
Xin-Bao Xu, Department of Hepatobiliary Surgery, Airforce General Hospital, Beijing 100036, China
Jing-Xiu Cai, Jia-Hong Dong, Ben-Li Han, Zheng-Ping He, Center of Hepatobiliary Surgery, Southwest Hospital, The Third Military Medical University, Chongqing 400038, China
Author contributions: All authors contributed equally to the work.
Correspondence to: Xin-Bao Xu, Department of Hepatobiliary Surgery, People’s Hospital, Peking University, Beijing 100044, China. x_xb@163.net
Telephone: +86-10-68792703
Received: June 29, 2004
Revised: July 5, 2004
Accepted: July 11, 2004
Published online: August 7, 2005
Abstract

AIM: To review the experience in surgery for 508 patients with portal hypertension and to explore the selection of reasonable operation under different conditions.

METHODS: The data of 508 patients with portal hypertension treated surgically in 1991-2001 in our centers were analyzed. Of the 508 patients, 256 were treated with portaazygous devascularization (PAD), 167 with portasystemic shunt (PSS), 62 with selective shunt (SS), 11 with combined portasystemic shunt and portaazygous devascularization (PSS+PAD), 9 with liver transplantation (LT), 3 with union operation for hepatic carcinoma and portal hypertension (HCC+PH).

RESULTS: In the 167 patients treated with PSS, free portal pressure (FPP) was significantly higher in the patients with a longer diameter of the anastomotic stoma than in those with a shorter diameter before the operation (P<0.01). After the operation, FPP in the former patients markedly decreased compared to the latter ones (P<0.01). The incidence rate of hemorrhage in patients treated with PAD, PSS, SS, PSS+PAD, and HCC+PH was 21.09% (54/256), 13.77 (23/167), 11.29 (7/62), 36.36% (4/11), and 100% (3/3), respectively. The incidence rate of hepatic encephalopathy was 3.91% (10/256), 9.58% (16/167), 4.84% (3/62), 9.09% (1/11), and 100% (3/3), respectively while the operative mortality was 5.49% (15/256), 4.22% (7/167), 4.84% (3/62), 9.09% (1/11), and 66.67% (2/3) respectively. The operative mortality of liver transplantation was 22.22% (2/9).

CONCLUSION: Five kinds of operation in surgical treatment of portal hypertension have their advantages and disadvantages. Therefore, the selection of operation should be based on the actual needs of the patients.

Keywords: Portal hypertension; Surgical operation; Shunt